Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Calvin J. Koh"'
Publikováno v:
Clinical Endoscopy, Vol 54, Iss 3, Pp 441-442 (2021)
Externí odkaz:
https://doaj.org/article/4f2f52557ac740cab855161bbf38b745
Publikováno v:
VideoGIE, Vol 5, Iss 1, Pp 24-25 (2020)
Externí odkaz:
https://doaj.org/article/90a3add0651748b2a9e10e3a3ae51339
Autor:
Vikneswaran Namasivayam, Calvin J Koh, Stephen Tsao, Jonathan Lee, Khoon Lin Ling, Christopher Khor, Tony Lim, James Weiquan Li, Benjamin CH Yip, Ikram Hussain, Tju Siang Chua, Bin Chet Toh, Hock Soo Ong, Lai Mun Wang, Jimmy BY So, Ming Teh, Khay Guan Yeoh, Tiing Leong Ang
Publikováno v:
Annals of the Academy of Medicine, Singapore. 51:417-435
Gastric cancer (GC) has a good prognosis, if detected at an early stage. The intestinal subtype of GC follows a stepwise progression to carcinoma, which is treatable with early detection and intervention using high-quality endoscopy. Premalignant les
Autor:
Si-Ying Tang, Jonathan Lee, Calvin J Koh, Feng Zhu, Jimmy So, Khek-Yu Ho, Supriya Srivastava, Stephen Tsao, Christopher Khor, Kwong-Ming Fock, Wee-Chian Lim, Khoon-Lin Ling, Tiing-Leong Ang, Ming Teh
Publikováno v:
Basic Gastroenterology.
Autor:
Jia Wei Ang, Colin Chia, Calvin J. Koh, Brandon W. B. Chua, Shyamala Narayanaswamy, Limin Wijaya, Lai Gwen Chan, Wei Leong Goh, Shawn Vasoo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30e477759b4c4b5f7111f0a4070e05be
https://doi.org/10.1142/9789811255038_0014
https://doi.org/10.1142/9789811255038_0014
Autor:
Jia Wei Ang, Colin Chia, Calvin J. Koh, Brandon W. B. Chua, Shyamala Narayanaswamy, Limin Wijaya, Lai Gwen Chan, Wei Leong Goh, Shawn Vasoo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c010bb3a9a4bf4dde420070d55532ff4
https://doi.org/10.1142/9789811255038_0015
https://doi.org/10.1142/9789811255038_0015
Autor:
Ying Jiao, Zhao, Ai Leng, Khoo, Liang, Lin, Monica, Teng, Calvin J, Koh, Seng Gee, Lim, Boon Peng, Lim, Yock Young, Dan
Publikováno v:
Journal of gastroenterology and hepatology. 31(9)
The high cost of chronic hepatitis C (HCV) direct-acting antivirals (DAAs) poses significant financial challenges for health payers, especially in Asia. A personalized treatment strategy based on individualized probability of virological response usi